RETHINKING
LIFESCIENCE

Secure the

Future

About us

  • Pharmaceutical, Medtech and Biotech services, manufacturing and development.
  • The LifeScience Investors Group AG ("LIG") comprises a team of experts in long-term oriented investments targeted specifically at companies or assets in the pharmaceutical and chemical industry, medical technology and life science services such as hospitals with an individual sales volume of € 10 to 300 million.
  • LifeScience Investors Group AG brings more than 20 years of experience in advising major corporations, banks and entrepreneurs on carveout and spin-off issues of companies and parts of companies that are no longer part of the core business.

We acquire and manage assets worldwide in:

  • Traditional pharmaceuticals, e.g. API and antibiotics
  • Biopharmaceuticals
  • Specialty pharmaceuticals, e.g. high potency hormonal compounds
  • Diagnostics
  • Development and production of medical devices
  • Packaging and service

LifeScience Investors Group AG is specialized in corporate groups, corporate spin-offs, special situations (turn-around situations) and succession planning of private and group assets and companies. In the long term, LifeScience Investors Group AG aims to strategically realign the acquired companies and lead them to sustainable growth. In this approach, entrepreneurial autonomy has proven to be the ideal long-term concept.

The shareholders and investors of the LifeScience Investors Group AG are entrepreneurs who are accustomed to making independent and swift decisions. We consider ourselves as an “Executive Private Equity Group”.

The partners and investors of LifeScience Investors Group AG invest in the equity of a portfolio company on a case-to-case basis.

Nevertheless, the actual operations management of the company always remains within the hands of the company’s own and experienced
managing directors

Philosophy

LifeScience Investors Group AG invests in companies that embody traditional corporate values worthy of development.

more

Investors

The investors of LifeScience Investors Group AG are predominantly independent, high-net-worth private investors as well.

more

Team

The LifeScience Investors Group AG team consists of qualified
partners who have experience in entrepreneurial responsibility.

more

Sustainable ESG-aligned

Company Development

  • Focus on LifeScience regulatory environment and corporate strategy, concentration on core business, separation of non-core activities
  • Sale to entrepreneurs, equity financing
  • Securing independence through optimized corporate strategy and organization
  • Professional repositioning and restructuring process
  • Stabilization of profitability through exploitation of new revenue potentials and cost reduction
  • Sustainable corporate development (consolidation, "buy-and-build")
  • Fast, professional transaction processing, maximum transaction security
  • Assumption of social responsibility, preservation of jobs and employment
  • Regulation of company succession plans, coordination of shareholder interests
  • New perspectives for your company and employees
  • Management support by experienced managers, consultants and functional specialists
LifeScience Investors Group AG Sihleggstrasse 23, CH-8832 Wollerau, Switzerland